Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates.

Clinical Microbiology and Infection

Volumn 16, Issue 2, 2010, Pages 132-136

  Lopez Cerero L ^a   Picon E ^b   Morillo, C ^b   Hernandez J R ^b   Docobo, F ^c   Pachon J ^c   Rodriguez Bano J ^a   Pascual, A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Amoxycillin clavulanate; Extended spectrum lactamase; Inoculum effect; Piperacillin tazobactam

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

AGAR DILUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ESCHERICHIA COLI;

EID: 74549187084     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02893.x     Document Type: Article

References (24)

1. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
2. Cantón R, Novais A, Valverde A. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14(suppl 1):144-153.
3. Tolun V, Kucukbasmaci O, Torumkuney-Akbulut D. Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin Microbiol Infect 2004, 10:72-75.
4. Pagani L, Migliavacca R, Luzzaro F. Comparative activity of piperacillin/tazobactam against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae. Chemotherapy 1998, 44:377-384.
5. Spanu T, Luzzaro F, Perilli M. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 2002, 46:196-202.
6. Gavin PJ, Suseno MT, Thomson RB. Clinical correlation of the CLSI susceptibility breakpoint for piperacillin-tazobactam against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Antimicrob Agents Chemother 2006, 50:2244-2247.
7. Peterson LR. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin Microbiol Infect 2008, 14(suppl 1):181-184.
8. Jett DD, Ritchie DJ, Reichley R. In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins. Antimicrob Agents Chemother 1995, 39:1187-1190.
9. Leleu G, Kitzis MD, Vallois JM. Different ratios of the piperacillin-tazobactam combinations for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase. Antimicrob Agents Chemother 1994, 38:195-199.
10. Segatore B, Setacci D, Perilli M. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes. Int J Antimicrob Agents 2004, 23:480-486.
11. Thomson KS, Moland ES. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2001, 45:3548-3554.
12. Hernández JR, Martínez-Martínez L, Cantón R. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2005, 49:2122-2125.
13. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2006, Approved standard M7-A7, Wayne, PA, CLSI
14. Methods for determining bactericidal activity of antimicrobial agents 1999, Approved standard M26-A, Wayne, PA, NCCLS
15. Soriano F, García-Corbeira P, Ponte C. Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model. Antimicrob Agents Chemother 1996, 40:2686-2690.
16. Goldstein EJ, Citron DM, Cherubin CE. Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations. Antimicrob Agents Chemother 1991, 35:560-566.
17. Burgess DS, Hall RG. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamases and non-ESBL producing Klebsiella pneumoniae. Diagn Microbiol Infect Dis 2004, 49:41-46.
18. Curtis NA, Orr D, Ross GW. Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K-12 and their antibacterial activity. Antimicrob Agents Chemother 1979, 16:533-539.
19. Mitsuyama J, Takahata M, Yasuda T. The mechanism of action of piperacillin-analogues in vitro; effect of the carbon number at the N-4 position of 2,3-dioxopiperazine on the outer membrane permeability, stability to beta-lactamase and binding affinity to penicillin-binding proteins. J Antibiot (Tokyo) 1987, 40:868-872.
20. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 2008, 32:234-258.
21. Spratt BG, Jobanputra V, Zimmermann W. Binding of thienamycin and clavulanic acid to the penicillin-binding proteins of Escherichia coli K-12. Antimicrob Agents Chemother 1977, 12:406-409.
22. Burgess DS, Hall RG, Lewis JS. Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period. Pharmacotherapy 2003, 23:1232-1237.
23. Paterson DL, Singh N, Gayowski T. Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis. Clin Infect Dis 1999, 28:683-684.
24. Zimhony O, Chmelnitsky I, Bardenstein R. Endocarditis caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin/tazobactam during treatment despite initial susceptibility. Antimicrob Agents Chemother 2006, 50:3179-3182.